Azitra has announced the screening and upcoming enrollment of the first patient in the Phase 1b trial of ATR-12, targeting Netherton Syndrome.
Dermatology Company Announces First Patient Enrollment In Netherton Syndrome Trial
Dermatology Company Announces First Patient…
Dermatology Company Announces First Patient Enrollment In Netherton Syndrome Trial
Azitra has announced the screening and upcoming enrollment of the first patient in the Phase 1b trial of ATR-12, targeting Netherton Syndrome.